KMT2A and acute lymphoblastic leukemia: Infants (<1 year) represent approximately 2-5% of ALL cases and are considered a distinct biological subgroup characterized by unique genetic abnormalities, such as mixed-lineage leukemia (MLL) rearrangements, and significantly inferior prognosis compared to older children [1,2].